Intuitive Surgical (NASDAQ:ISRG) SVP Sells $1,177,882.16 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the sale, the senior vice president directly owned 3,554 shares of the company’s stock, valued at $1,772,308.72. This represents a 39.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Mark Brosius also recently made the following trade(s):

• On Thursday, March 5th, Mark Brosius sold 648 shares of Intuitive Surgical stock. The shares were sold at an average price of $495.20, for a total transaction of $320,889.60.
• On Tuesday, March 3rd, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $488.10, for a total transaction of $316,288.80.
• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total value of $254,499.36.
• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $4.48 on Thursday, hitting $496.70. 1,541,063 shares of the stock were exchanged, compared to its average volume of 2,057,887. The business’s fifty day moving average is $525.02 and its 200 day moving average is $512.10. The company has a market capitalization of $176.39 billion, a PE ratio of 62.95, a P/E/G ratio of 3.83 and a beta of 1.66. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The business’s revenue was up 18.8% on a year-over-year basis. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ISRG. UBS Group set a $570.00 target price on Intuitive Surgical and gave the company a “neutral” rating in a report on Tuesday, February 24th. BTIG Research reiterated a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a report on Friday, January 23rd. Robert W. Baird reduced their target price on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a report on Friday, January 23rd. Raymond James Financial boosted their target price on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Finally, Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $615.86.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the stock. Storen Legacy Partners LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $217,000. Worthington Financial Partners LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $366,000. AG Campbell Advisory LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $368,000. Pure Financial Advisors LLC lifted its position in shares of Intuitive Surgical by 5.8% in the fourth quarter. Pure Financial Advisors LLC now owns 2,245 shares of the medical equipment provider’s stock worth $1,271,000 after buying an additional 124 shares in the last quarter. Finally, Rehmann Capital Advisory Group lifted its position in Intuitive Surgical by 6.9% during the fourth quarter. Rehmann Capital Advisory Group now owns 2,078 shares of the medical equipment provider’s stock valued at $1,178,000 after purchasing an additional 135 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.